A high-throughput screen identifies a candidate molecule that promotes remyelination with significant translational potential (S50.003)

Conclusions:Taken together, BZA represents a particularly potent and attractive SERM that could be mediating OPC differentiation and myelination effects, with significant translational potential.Study Supported by: National Multiple Sclerosis Society.Disclosure: Dr. Rankin has nothing to disclose. Dr. Shen has nothing to disclose. Dr. Mei has nothing to disclose. Dr. Desponts has received personal compensation for activities with Inception Sciences as an employee. Dr. Desponts holds stock and/or stock options in Inception Sciences. Dr. Lorrain has received personal compensation for activities with Inception. Dr. Green has received personal compensation for activities with Inception Sciences, Mylan Pharma, Medimmune, and Bionure. Dr. Green has received personal compensation for serving on the board of Inception Sciences. Dr. Green holds stock and/or stock options in Inception Sciences. Dr. Green has received research support from Inception Sciences, Biogen, and Novartis. Dr. Chan has received personal compensation for activities with Inception. Dr. Bove has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: MS Novel Therapeutics and Animal Models Source Type: research